Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $361,439.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Cecil Haney sold 1,300 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $278.03, for a total transaction of $361,439.00. Following the completion of the transaction, the director owned 12,553 shares of the company’s stock, valued at $3,490,110.59. This trade represents a 9.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Tenet Healthcare Trading Up 0.8%

THC stock traded up $2.18 during trading on Wednesday, reaching $274.06. The company had a trading volume of 513,308 shares, compared to its average volume of 844,938. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $283.05. The business has a 50 day moving average of $226.21 and a 200 day moving average of $208.66. The company has a market cap of $22.07 billion, a P/E ratio of 10.57, a PEG ratio of 1.04 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts forecast that Tenet Healthcare Corporation will post 20.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

THC has been the topic of a number of recent research reports. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. TD Cowen lifted their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research note on Monday, July 27th. Mizuho set a $290.00 target price on Tenet Healthcare in a research note on Monday, August 10th. Truist Financial upped their price target on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. Finally, Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $273.00.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. NewEdge Advisors LLC increased its position in Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares in the last quarter. Jones Financial Companies Lllp increased its stake in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC purchased a new position in shares of Tenet Healthcare during the 2nd quarter valued at $290,000. Quantbot Technologies LP bought a new position in Tenet Healthcare in the 2nd quarter worth $65,000. Finally, Amundi lifted its position in shares of Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after acquiring an additional 26,383 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.